CD8A and neoplasm: PDAC paired biopsies (before and after treatment) revealed a modification of the immune components within the primary tumor with increased proliferative CD8+ lymphocytes and decreased macrophages and stromal density [317], validating the impact of the treatment on PDAC stromal normalization.